Citi Depository Receipt Services Mid-Year 2017 Report

15 / 40

DR ACCESS PRODUCTS
ABOUT CITI DEPOSITARY
RECEIPT SERVICES
INTERNATIONAL
INVESTING TRENDS
GLOBAL DR TRENDS
*Signifies Citi DR program capital raising.
Deals in bold italics signify a JOBS Act Deal.
1 Defined as capital raising at the time of listing of additional DR securities including rights offerings, and private placements.
Data as of June 30, 2017
2 Industry as defined by Bloomberg.
Issuer Country Industry2 USD Value
(in Millions)
Banco Macro S.A. Argentina Regional Banks $598
Banco Santander Brasil SA Brazil Regional Banks $469
Galapagos NV* Belgium Biotechnology $388
Melco Resorts & Entertainment
Ltd Hong Kong Casinos/Gaming $337
Veon Netherlands Wireless
Telecommunications $263
International Ltd. China Consumer Services $172
Talend SA France Packaged Software $108
Adaptimmune Therapeutics plc* UK Biotechnology $108
BioLineRX Israel Pharmaceuticals $29
Sequans Communications SA France Semiconductors $14
Can-Fite BioPharma Israel Biotechnology $5
Medigus Ltd Israel Medical Specialties $3
XTL Biopharmaceuticals Ltd. Israel Biotechnology $3
Grand Total $2,496
DR Follow-On Offerings1
Source: Bloomberg and Depositary Data Interchange.
15
Citi Depositary Receipt Services Mid-Year 2017 Report